IL: Medical cannabis reform failed to reach 86% of export goals - analysis

A report which was released last weekend by the Citizens' Empowerment Center in Israel (CECI) confirmed what thousands of Israeli medical cannabis patients have known for years, former health minister Ya'acov Litzman's medical cannabis reform has been an overwhelming failure.
The reform's failure in the export field became especially embarrassing in July of 2020 when it was announced that Israel had overtaken Germany as the largest importer of medical cannabis in the world.
However, while most of the complaints from patients have been related to the reform's failures within the state of Israel, the CECI report details the ways in which Israel went from expecting a bustling international medical cannabis export powerhouse to ending up with the conditions which led Panaxia to become the country's sole cannabis exporter, essentially granting the medical cannabis giant an export monopoly.
The report tracked the goals which the government set in Government Resolution 4490, which aimed at regulating and promoting Israel's medical cannabis export industry, which was expected to add around NIS 4 billion to the state budget and give Israel an early lead in the quickly emerging international market.


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber